{"id":54383,"date":"2026-02-23T23:53:21","date_gmt":"2026-02-23T23:53:21","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/global-general-anesthesia-drugs-market-mordor\/"},"modified":"2026-09-25T03:12:37","modified_gmt":"2026-09-24T18:12:37","slug":"global-general-anesthesia-drugs-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/global-general-anesthesia-drugs-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc804\uc2e0 \ub9c8\ucde8 \uc758\uc57d\ud488 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026 &#8211; 2031)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/global-general-anesthesia-drugs-market_1676449189089_Competitive_Landscape.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/global-general-anesthesia-drugs-market-size-image-1770809287724.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc804 \uc138\uacc4 \uc218\uc220\ub7c9 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc81c\ud488 \uc2b9\uc778 \ubc0f \ucd9c\uc2dc \uae09\uc99d<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc678\ub798 \uc218\uc220 \uc13c\ud130 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.4 AI \uae30\ubc18 \ud3d0\uc1c4 \ub8e8\ud504 \uc8fc\uc785 \ucc44\ud0dd<\/li>\n<li class=\"toc-level-3\">4.2.5 \uc218\uc220 \uc808\ucc28\ub7c9 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.6 \uce5c\ud658\uacbd \uc800GWP \ud761\uc785 \ub9c8\ucde8\uc81c\ub85c\uc758 \uc804\ud658<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ubd80\uc791\uc6a9 \ud504\ub85c\ud544 \ubc0f PONV(\uc218\uc220 \ud6c4 \uc624\uc2ec \ubc0f \uad6c\ud1a0) \uc6b0\ub824<\/li>\n<li class=\"toc-level-3\">4.3.2 \ud504\ub9ac\ubbf8\uc5c4 \uc81c\uc81c\uc5d0 \ub300\ud55c \uc0c1\ud658 \uc555\ub825<\/li>\n<li class=\"toc-level-3\">4.3.3 IV \uc720\uc81c\uc6a9 API-\uc9c0\uc9c8 \uacf5\uae09\ub9dd\uc758 \ubd88\uc548\uc815\uc131<\/li>\n<li class=\"toc-level-3\">4.3.4 \uace0GWP \uac00\uc2a4\uc5d0 \ub300\ud55c \ud658\uacbd\uc138<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc57d\ubb3c \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \ud504\ub85c\ud3ec\ud3f4<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc138\ubcf4\ud50c\ub8e8\ub780<\/li>\n<li class=\"toc-level-3\">5.1.3 \ub370\uc2a4\ud50c\ub8e8\ub780<\/li>\n<li class=\"toc-level-3\">5.1.4 \ub371\uc2a4\uba54\ub370\ud1a0\ubbf8\ub518<\/li>\n<li class=\"toc-level-3\">5.1.5 \ub808\ubbf8\ud39c\ud0c0\ub2d0<\/li>\n<li class=\"toc-level-3\">5.1.6 \ubbf8\ub2e4\uc878\ub78c<\/li>\n<li class=\"toc-level-3\">5.1.7 \uc5d0\ud1a0\ubbf8\ub370\uc774\ud2b8<\/li>\n<li class=\"toc-level-3\">5.1.8 \ucf00\ud0c0\ubbfc<\/li>\n<li class=\"toc-level-3\">5.1.9 \uae30\ud0c0 \uc57d\ubb3c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \ud22c\uc5ec \uacbd\ub85c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ud761\uc785<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc815\ub9e5 \uc8fc\uc0ac (TIVA)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc801\uc6a9 \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc77c\ubc18 \uc218\uc220<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc554 \uc218\uc220<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc2ec\uc7a5 \uc218\uc220<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc815\ud615\uc678\uacfc \uad50\uccb4\uc220<\/li>\n<li class=\"toc-level-3\">5.3.5 \uc2e0\uacbd\uc678\uacfc \uc218\uc220<\/li>\n<li class=\"toc-level-3\">5.3.6 \uae30\ud0c0 \uc801\uc6a9 \ubd84\uc57c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubcd1\uc6d0<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc678\ub798 \uc218\uc220 \uc13c\ud130<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc804\ubb38 \ubc0f \uce58\uacfc \uc9c4\ub8cc\uc18c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74 \uacf5\ud654\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34, \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 AbbVie Inc.<\/li>\n<li class=\"toc-level-3\">6.3.2 Aspen Pharmacare Holdings Limited<\/li>\n<li class=\"toc-level-3\">6.3.3 AstraZeneca plc<\/li>\n<li class=\"toc-level-3\">6.3.4 Avet Pharmaceuticals Inc.<\/li>\n<li class=\"toc-level-3\">6.3.5 B. Braun SE<\/li>\n<li class=\"toc-level-3\">6.3.6 Baxter International Inc.<\/li>\n<li class=\"toc-level-3\">6.3.7 Dr. Reddys Laboratories Limited<\/li>\n<li class=\"toc-level-3\">6.3.8 Endo International plc<\/li>\n<li class=\"toc-level-3\">6.3.9 Fresenius Kabi AG<\/li>\n<li class=\"toc-level-3\">6.3.10 Hikma Pharmaceuticals plc<\/li>\n<li class=\"toc-level-3\">6.3.11 Jiangsu Hengrui Pharmaceuticals Co., Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.12 Jiangsu Nhwa Pharmaceutical Co., Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.13 Lunan Pharmaceutical Group Limited<\/li>\n<li class=\"toc-level-3\">6.3.14 Maruishi Pharmaceutical Co., Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.15 PAION Pharma GmbH<\/li>\n<li class=\"toc-level-3\">6.3.16 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.17 Piramal Critical Care Limited<\/li>\n<li class=\"toc-level-3\">6.3.18 Teva Pharmaceutical Industries Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.19 Xian Libang Pharma<\/li>\n<li class=\"toc-level-3\">6.3.20 Yichang Humanwell Pharmaceutical Co., Ltd.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc804\uc2e0 \ub9c8\ucde8\uc81c \uc2dc\uc7a5 \uaddc\ubaa8, \uc810\uc720\uc728, \ub3d9\ud5a5 \ubc0f \uacbd\uc7c1 \ud658\uacbd 2031\ub144 \ubd84\uc11d \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p># 1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc8fc\uc694 \uc218\uce58<\/p>\n<p>\uc804\uc2e0 \ub9c8\ucde8\uc81c \uc2dc\uc7a5\uc740 2025\ub144 54\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2031\ub144 67\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc608\uce21 \uae30\uac04(2026-2031\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 3.54%\ub97c \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \uc218\uc220 \uac74\uc218 \uc99d\uac00, \uc885\uc591\ud559 \uad00\ub828 \uc218\uc220\uc758 \ubcf5\uc7a1\uc131 \uc99d\ub300, \uadf8\ub9ac\uace0 \uce5c\ud658\uacbd\uc801\uc774\uac70\ub098 \uc2e0\uc18d\ud55c \uc791\uc6a9\uc744 \ud558\ub294 \uc57d\ubb3c\ub85c\uc758 \uc804\ud658\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ud2b9\ud5c8 \ub9cc\ub8cc \uc57d\ubb3c\uc758 \uac00\uaca9 \ud558\ub77d\uacfc \uc608\uc0b0 \uc81c\uc57d\uc740 \uc2dc\uc7a5 \uac00\uce58 \uc0c1\uc2b9\uc744 \uc5b5\uc81c\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc57d\ubb3c \uc720\ud615(\ud504\ub85c\ud3ec\ud3f4, \uc138\ubcf4\ud50c\ub8e8\ub780, \ub370\uc2a4\ud50c\ub8e8\ub780, \ub371\uc2a4\uba54\ub370\ud1a0\ubbf8\ub518 \ub4f1), \ud22c\uc5ec \uacbd\ub85c(\ud761\uc785, \uc815\ub9e5), \uc801\uc6a9 \ubd84\uc57c(\uc77c\ubc18 \uc218\uc220, \uc554 \uc218\uc220, \uc2ec\uc7a5 \uc218\uc220 \ub4f1), \ucd5c\uc885 \uc0ac\uc6a9\uc790(\ubcd1\uc6d0, \uc678\ub798 \uc218\uc220 \uc13c\ud130 \ub4f1) \ubc0f \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \ub4f1)\ubcc4\ub85c \uc2dc\uc7a5\uc744 \ubd84\uc11d\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc2a4\ub0c5\uc0f7 (2026-2031\ub144 \uc608\uce21):<br \/>\n*   \uc5f0\uad6c \uae30\uac04: 2020\ub144 &#8211; 2031\ub144<br \/>\n*   2026\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 56\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   2031\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 67\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   \uc131\uc7a5\ub960 (2026-2031\ub144): 3.54% CAGR<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<br \/>\n*   \uac00\uc7a5 \ud070 \uc2dc\uc7a5: \ubd81\ubbf8<br \/>\n*   \uc2dc\uc7a5 \uc9d1\uc911\ub3c4: \uc911\uac04<br \/>\n*   \uc8fc\uc694 \uae30\uc5c5: Baxter International Inc., Fresenius SE &#038; Co. KGaA, Pfizer Inc., AbbVie Inc., Aspen Pharmacare Holdings Ltd., B. Braun SE \ub4f1<\/p>\n<p># 2. \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\uc778<\/p>\n<p>\uc804\uc2e0 \ub9c8\ucde8\uc81c \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\ub4e4\uc740 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc804 \uc138\uacc4 \uc218\uc220 \uac74\uc218 \uc99d\uac00: 2025\ub144 \uc804 \uc138\uacc4 \uc218\uc220 \uac74\uc218\ub294 4\uc5b5 \uac74\uc744 \ub118\uc5b4\uc130\uc73c\uba70, \uc774\ub294 \uace0\ub839\ud654 \uc778\uad6c, \ubcf4\ud5d8 \uc801\uc6a9 \ud655\ub300, \ud32c\ub370\ubbf9\uc73c\ub85c \uc778\ud55c \uc218\uc220 \uc801\uccb4 \ud574\uc18c \ub4f1\uc5d0 \ud798\uc785\uc5b4 \uc804\ub144 \ub300\ube44 4.2% \uc99d\uac00\ud55c \uc218\uce58\uc785\ub2c8\ub2e4. \uace0\uc18c\ub4dd \uad6d\uac00\uc5d0\uc11c\ub294 \ubcf5\uc7a1\ud558\uace0 \uc7a5\uc2dc\uac04\uc774 \uc18c\uc694\ub418\ub294 \uc218\uc220\uc774 \uc99d\uac00\ud558\uace0 \uc788\uc73c\uba70, \uc2e0\ud765 \uc2dc\uc7a5\uc5d0\uc11c\ub294 \ud544\uc218 \uc218\uc220\uc774 \ud655\ub300\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \uc911\uad6d\uc758 &#8216;\uac74\uac15\ud55c \uc911\uad6d 2030&#8217; \uacc4\ud68d\uacfc \uc778\ub3c4\uc758 &#8216;\uc544\uc720\uc288\ub9cc \ubc14\ub77c\ud2b8(Ayushman Bharat)&#8217; \ud504\ub85c\uadf8\ub7a8\uc740 \uc218\uc220 \uc778\ud504\ub77c \ud655\ucda9 \ubc0f \uc218\uc220 \uc218\ud61c\uc790 \uc99d\uac00\ub97c \ud1b5\ud574 \ub9c8\ucde8\uc81c \uc218\uc694\ub97c \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc2e0\uc81c\ud488 \uc2b9\uc778 \ubc0f \ucd9c\uc2dc \uc99d\uac00: \uc2dc\ud504\ub85c\ud3f4(ciprofol)\uacfc \ub808\ubbf8\ub9c8\uc878\ub78c(remimazolam)\uc758 \uc2e0\uc18d\ud55c \uc2b9\uc778\uc740 \ub9c8\ucde8\uacfc \uc758\uc0ac\uc758 \uce58\ub8cc \ub3c4\uad6c\ub97c \ud655\uc7a5\ud558\uc5ec \uc8fc\uc0ac \ubd80\uc704 \ud1b5\uc99d\uc744 \uc904\uc774\uace0 \uc2ec\ud608\uad00 \uc548\uc815\uc131\uc744 \ud5a5\uc0c1\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. \ubbf8\uad6d FDA\uc758 JOURNAVX(suzetrigine) \uc2b9\uc778\uc740 \ube44\ub9c8\uc57d\uc131 \uc218\uc220 \uc804\ud6c4 \uc9c4\ud1b5\uc81c\uc5d0 \ub300\ud55c \uc804\ud658\uc744 \uac15\uc870\ud558\uba70, Amneal\uc758 \ub2e8\uc77c \uc6a9\ub7c9 \ud504\ub85c\ud3ec\ud3f4 \ubc14\uc774\uc54c \ucd9c\uc2dc\ub294 \uacf5\uae09 \ubd80\uc871 \uc644\ud654\uc5d0 \uae30\uc5ec\ud558\uba70 \uc2dc\uc7a5 \uacbd\uc7c1\uc744 \uc2ec\ud654\uc2dc\ud0a4\uace0 \ud601\uc2e0\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc678\ub798 \uc218\uc220 \uc13c\ud130(ASC) \ucc44\ud0dd \uc99d\uac00: \ubbf8\uad6d ASC \uc9c0\ucd9c\uc740 2022\ub144 61\uc5b5 \ub2ec\ub7ec\uc5d0 \ub2ec\ud588\uc73c\uba70, 2021\ub144 370\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2028\ub144 590\uc5b5 \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. CMS(\uba54\ub514\ucf00\uc5b4 \ubc0f \uba54\ub514\ucf00\uc774\ub4dc \uc11c\ube44\uc2a4 \uc13c\ud130)\uac00 \uc9c0\uc6d0\ud558\ub294 NOPAIN \ubc95\uc548\uc740 2025\ub144 1\uc6d4\ubd80\ud130 EXPAREL\uacfc \uac19\uc740 \ube44\ub9c8\uc57d\uc131 \uc9c4\ud1b5\uc81c\uc5d0 \ub300\ud55c \ubcc4\ub3c4 \uc0c1\ud658\uc744 \ud5c8\uc6a9\ud558\uc5ec \uc678\ub798 \ud658\uacbd\uc5d0\uc11c \ube60\ub978 \ud68c\ubcf5 \ub9c8\ucde8 \ud504\ub85c\ud1a0\ucf5c\uc758 \uacbd\uc81c\uc131\uc744 \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. ASC\uc758 \ud655\uc7a5\uc740 \uc2dc\ud504\ub85c\ud3f4\uacfc \uac19\uc740 \uc2e0\uc18d \uc791\uc6a9 \uc57d\ubb3c\uc5d0 \ub300\ud55c \uc218\uc694\ub97c \uc99d\uac00\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   AI \uae30\ubc18 \ud3d0\uc1c4 \ub8e8\ud504 \uc8fc\uc785 \uc2dc\uc2a4\ud15c \ub3c4\uc785: \uc2e4\uc2dc\uac04 EEG \ubc0f \ud608\uc5ed\ud559\uc801 \ud53c\ub4dc\ubc31\uc744 \ud65c\uc6a9\ud558\uc5ec \ud504\ub85c\ud3ec\ud3f4 \ubc0f \ub808\ubbf8\ud39c\ud0c0\ub2d0 \uc8fc\uc785\uc744 \uc870\uc808\ud558\ub294 \ud3d0\uc1c4 \ub8e8\ud504 \ud50c\ub7ab\ud3fc\uc740 \uc218\ub3d9 \ud22c\uc5ec \ub300\ube44 \uc218\uc220 \uc911 \uc548\uc815\uc131\uc744 15-20% \ud5a5\uc0c1\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. \ucd08\uae30 \ub3c4\uc785 \ubcd1\uc6d0\ub4e4\uc740 \uc57d\ubb3c \uc18c\ube44\ub7c9\uc740 \uc57d\uac04 \uc99d\uac00\ud558\uc9c0\ub9cc \uc218\uc220 \ud6c4 \ud569\ubcd1\uc99d \uac10\uc18c\ub85c \uc778\ud574 \uc21c \uacbd\uc81c\uc801 \uc774\ub4dd\uc744 \ubcf4\uace0 \uc788\uc2b5\ub2c8\ub2e4. GE HealthCare\uc758 Aisys CS\u00b2 \uc6cc\ud06c\uc2a4\ud14c\uc774\uc158\uc740 \uc57d\ubb3c \uc18c\ube44\ub97c 18-22% \uc904\uc774\ub294 \ud6a8\uacfc\ub97c \ubcf4\uc600\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uce5c\ud658\uacbd \uc800\uc9c0\uad6c\uc628\ub09c\ud654\uc9c0\uc218(GWP) \ud761\uc785 \ub9c8\ucde8\uc81c \uc804\ud658: \uc720\ub7fd\uc758 \ud658\uacbd \uaddc\uc81c \uac15\ud654\ub85c \uc778\ud574 \uc800GWP \ud761\uc785 \ub9c8\ucde8\uc81c\uc5d0 \ub300\ud55c \uc218\uc694\uac00 \uc99d\uac00\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 \ud2b9\ud788 \uc720\ub7fd \uc9c0\uc5ed\uc5d0\uc11c \uc911\uc694\ud55c \uc131\uc7a5 \ub3d9\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4. \uc601\uad6d, \ub3c5\uc77c, \ubd81\uc720\ub7fd \uad6d\uac00\ub4e4\uc774 \uc774\ub7ec\ud55c \uc804\ud658\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc73c\uba70, \uce90\ub098\ub2e4\uc640 \ud638\uc8fc\uc5d0\uc11c\ub3c4 \uc720\uc0ac\ud55c \uc6c0\uc9c1\uc784\uc774 \ub098\ud0c0\ub098\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud544\uc218 \uc2dc\uc220\ub7c9 \uc99d\uac00: \uc800\uc18c\ub4dd \ubc0f \uc911\uac04 \uc18c\ub4dd \uc9c0\uc5ed\uc5d0\uc11c \ud544\uc218 \uc218\uc220 \uac74\uc218\uac00 \uc99d\uac00\ud558\uba74\uc11c \uc804\uc2e0 \ub9c8\ucde8\uc81c\uc5d0 \ub300\ud55c \uae30\ubcf8\uc801\uc778 \uc218\uc694\ub97c \uacac\uc778\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 3. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778<\/p>\n<p>\uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc8fc\uc694 \uc694\uc778\ub4e4\uc740 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \ubd80\uc791\uc6a9 \ubc0f \uc218\uc220 \ud6c4 \uc624\uc2ec \uad6c\ud1a0(PONV) \uc6b0\ub824: \ud718\ubc1c\uc131 \ub9c8\ucde8\uc81c \uc0ac\uc6a9 \uc2dc PONV \ubc1c\uc0dd\ub960\uc740 25-30%\ub85c, \ud504\ub85c\ud3ec\ud3f4 TIVA(Total Intravenous Anesthesia) \uc0ac\uc6a9 \uc2dc 10-15%\ubcf4\ub2e4 \ub192\uc2b5\ub2c8\ub2e4. PONV\ub294 \ud658\uc790\ub2f9 50-100\ub2ec\ub7ec\uc758 \ucd94\uac00 \ube44\uc6a9\uacfc 15-25\ubd84\uc758 PACU(\ub9c8\ucde8 \ud6c4 \ud68c\ubcf5\uc2e4) \uccb4\ub958 \uc2dc\uac04 \uc5f0\uc7a5\uc744 \ucd08\ub798\ud569\ub2c8\ub2e4. \ud504\ub85c\ud3ec\ud3f4 TIVA\uac00 PONV\ub97c 19%p \uac10\uc18c\uc2dc\ud0a4\uc9c0\ub9cc, \ud504\ub85c\ud3ec\ud3f4\uc758 \ub192\uc740 \ube44\uc6a9(\ucf00\uc774\uc2a4\ub2f9 8-12\ub2ec\ub7ec vs. \uc138\ubcf4\ud50c\ub8e8\ub780 4-6\ub2ec\ub7ec)\uc740 \ube44\uc6a9\uc5d0 \ubbfc\uac10\ud55c \uc2dc\uc2a4\ud15c\uc5d0\uc11c \uc644\uc804\ud55c \uc804\ud658\uc744 \uc5b4\ub835\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   \uace0\uac00 \uc57d\ubb3c\uc5d0 \ub300\ud55c \ubcf4\ud5d8 \uc0c1\ud658 \uc555\ub825: \uc0c1\uc5c5 \ubcf4\ud5d8 \ubc0f \uba54\ub514\ucf00\uc5b4 \uc218\uac00 \uc778\ud558, \uccad\uad6c \uac70\ubd80 \uc99d\uac00 \ub4f1\uc740 \ub9c8\ucde8 \uc11c\ube44\uc2a4 \uc81c\uacf5\uc790\uc5d0\uac8c \uc7ac\uc815\uc801 \ubd80\ub2f4\uc744 \uac00\uc911\uc2dc\ud0b5\ub2c8\ub2e4. \uc774\ub294 \ud6a8\uc728\uc131 \uac1c\uc120 \uc555\ub825\uc73c\ub85c \uc774\uc5b4\uc838 \uac1c\ubcc4\ud654\ub41c \uce58\ub8cc\ubcf4\ub2e4\ub294 \uc18d\ub3c4 \uc911\uc2ec\uc758 \uace0\ucc98\ub9ac\ub7c9 \ubaa8\ub378\ub85c \uc804\ud658\ub420 \uc218 \uc788\uc73c\uba70, \ubcf5\uc7a1\ud558\uace0 \uc2dc\uac04\uc774 \ub9ce\uc774 \uc18c\uc694\ub418\ub294 \ucf00\uc774\uc2a4\uc5d0 \ub300\ud55c \ubcf4\uc0c1 \uac10\uc18c\ub294 \ud658\uc790 \uc548\uc804\uc744 \uc800\ud574\ud560 \uc704\ud5d8\uc774 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc815\ub9e5 \uc8fc\uc0ac \uc720\uc81c\uc6a9 API-\uc9c0\uc9c8 \uacf5\uae09\ub9dd \ubd88\uc548\uc815: 2023-2024\ub144 \ub3d9\uc548 \ubc1c\uc0dd\ud55c \uacf5\uae09 \ubd80\uc871\uc740 \uc2dc\uc7a5\uc5d0 \ub2e8\uae30\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\ucce4\uc73c\uba70, \uc774\ub294 \uc815\ub9e5 \ub9c8\ucde8\uc81c \uc0dd\uc0b0\uc5d0 \ud544\uc694\ud55c \uc6d0\ub8cc\uc758\uc57d\ud488(API) \ubc0f \uc9c0\uc9c8 \uacf5\uae09\ub9dd\uc758 \ucde8\uc57d\uc131\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<br \/>\n*   \uace0GWP \uac00\uc2a4\uc5d0 \ub300\ud55c \ud658\uacbd\uc138 \ubd80\uacfc: \uc720\ub7fd(\uc601\uad6d, \ub3c5\uc77c) \ubc0f \uce90\ub098\ub2e4\uc5d0\uc11c \uace0GWP \ub9c8\ucde8\uc81c\uc5d0 \ub300\ud55c \ud658\uacbd\uc138 \ubd80\uacfc\uac00 \ucd94\uc9c4\ub418\uba74\uc11c \ud574\ub2f9 \uc57d\ubb3c\uc758 \uc0ac\uc6a9\uc774 \uc81c\ud55c\ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uc601\uad6d NHS\ub294 2024\ub144\uc5d0 \ub370\uc2a4\ud50c\ub8e8\ub780 \uc0ac\uc6a9\uc744 \uc804\uba74 \uc911\ub2e8\ud588\uc73c\uba70, \uc720\ub7fd \uc5f0\ud569\ub3c4 2026\ub144\uae4c\uc9c0 \uc9c0\uc5ed \uc804\uccb4 \uae08\uc9c0\ub97c \uac80\ud1a0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 4. \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>4.1. \uc57d\ubb3c \uc720\ud615\ubcc4:<br \/>\n\uc138\ubcf4\ud50c\ub8e8\ub780\uc740 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728 38.78%\ub85c \uc120\ub450\ub97c \uc720\uc9c0\ud588\uc73c\ub098, TIVA(Total Intravenous Anesthesia)\ub85c\uc758 \uc804\ud658 \ucd94\uc138\uc5d0 \ub530\ub77c \ud504\ub85c\ud3ec\ud3f4\uc740 2031\ub144\uae4c\uc9c0 4.98%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc2dc\ud504\ub85c\ud3f4\uc758 \ube44\uc5f4\ub4f1\uc131 \uc785\uc99d \ubc0f \uc8fc\uc0ac \ubd80\uc704 \ud1b5\uc99d \uac10\uc18c \ud6a8\uacfc\ub294 \ud504\ub85c\ud3ec\ud3f4 \uae30\ubc18 \uc81c\ud615 \uc2dc\uc7a5\uc744 \ub354\uc6b1 \ud655\ub300\ud560 \uac83\uc785\ub2c8\ub2e4. \ub370\uc2a4\ud50c\ub8e8\ub780\uc740 \uc720\ub7fd\uc758 \ud658\uacbd \uaddc\uc81c\ub85c \uc778\ud574 \ubd80\uc815\uc801\uc778 \uc131\uc7a5 \uada4\uc801\uc744 \ubcf4\uc774\uba70, \ub371\uc2a4\uba54\ub370\ud1a0\ubbf8\ub518\uacfc \ub808\ubbf8\ud39c\ud0c0\ub2d0\uc740 \ud2b9\uc815 \uc2dc\uc220\uc5d0 \ud2b9\ud654\ub41c \ud2c8\uc0c8\uc2dc\uc7a5\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubbf8\ub2e4\uc878\ub78c\uc758 \uc911\uad6d \ub0b4 \uaddc\uc81c \uac15\ud654\ub294 \ub808\ubbf8\ub9c8\uc878\ub78c\uc73c\ub85c\uc758 \uc804\ud658\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc73c\uba70, \ucf00\ud0c0\ubbfc\uacfc \uc5d0\ud1a0\ubbf8\ub370\uc774\ud2b8\ub294 \uc548\uc815\uc801\uc778 \uc18c\uaddc\ubaa8 \uc138\uadf8\uba3c\ud2b8\ub97c \ucc28\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4.2. \ud22c\uc5ec \uacbd\ub85c\ubcc4:<br \/>\n\ud761\uc785 \ud22c\uc5ec\ub294 2025\ub144 \uc18c\ube44\uc758 61.20%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \uc815\ub9e5 \ud22c\uc5ec\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 5.88%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc815\ub9e5 \uc81c\ud615 \uc2dc\uc7a5 \uaddc\ubaa8\ub294 2025\ub144 23\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 32\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc99d\uac00\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \ud718\ubc1c\uc131 \ubc30\ucd9c\ub7c9 \uac10\ucd95\uc744 \uc704\ud55c \ud658\uacbd\uc801 \uc694\uad6c, PACU \ucc98\ub9ac\ub7c9 \uc99d\ub300 \ud544\uc694\uc131, \uadf8\ub9ac\uace0 \uc2a4\ub9c8\ud2b8 \uc8fc\uc785 \ud38c\ud504\uc758 \uc57d\ubb3c \ub0ad\ube44 \uac10\uc18c \ud6a8\uacfc(\ucf00\uc774\uc2a4\ub2f9 30-50\ub2ec\ub7ec \uc808\uac10)\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4.<\/p>\n<p>4.3. \uc801\uc6a9 \ubd84\uc57c\ubcc4:<br \/>\n\uc77c\ubc18 \uc218\uc220\uc774 2025\ub144 \ub9e4\ucd9c\uc758 41.56%\ub97c \ucc28\uc9c0\ud588\uc9c0\ub9cc, \uc554 \uad00\ub828 \uc2dc\uc220\uc740 2031\ub144\uae4c\uc9c0 4.89%\uc758 CAGR\ub85c \uc131\uc7a5\uc744 \uc8fc\ub3c4\ud560 \uac83\uc785\ub2c8\ub2e4. \uc554 \uc218\uc220\uc774 \uc804\uc2e0 \ub9c8\ucde8\uc81c \uc2dc\uc7a5\uc5d0\uc11c \ucc28\uc9c0\ud558\ub294 \ube44\uc911\uc740 2025\ub144 15.4%\uc5d0\uc11c 2031\ub144 18.2%\ub85c \uc99d\uac00\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ub85c\ubd07 \ubcf4\uc870 \uc808\uc81c\uc220\uacfc \uac19\uc740 \uc554 \uc218\uc220\uc758 \uc99d\uac00\uc640 \uc7a5\uc2dc\uac04 \uc218\uc220\uc740 \ud608\uc5ed\ud559\uc801 \ubbf8\uc138 \uc870\uc815\uc744 \uc704\ud55c \ub2e4\uc911 \uc57d\ubb3c \uc694\ubc95\uc758 \uc218\uc694\ub97c \ub192\uc785\ub2c8\ub2e4. \uc815\ud615\uc678\uacfc \uc218\uc220\uc740 \ub808\ubbf8\ub9c8\uc878\ub78c\uc758 \ucd08\uace0\uc18d \ud68c\ubcf5 \ubc0f \uad6d\uc18c \ub9c8\ucde8 \ud65c\uc6a9\uc73c\ub85c ASC\ub85c \uc804\ud658\ub418\ub294 \ucd94\uc138\uc774\uba70, \uc2e0\uacbd\uc678\uacfc \uc218\uc220\uc740 \ub1cc \ub300\uc0ac \uc218\uc694\ub97c \uc81c\ud55c\ud558\uae30 \uc704\ud574 \ud504\ub85c\ud3ec\ud3f4\uc744 \uc120\ud638\ud569\ub2c8\ub2e4.<\/p>\n<p>4.4. \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4:<br \/>\n\ubcd1\uc6d0\uc740 2025\ub144 \uc18c\ube44\uc758 62.95%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2ec\uc7a5, \uc2e0\uacbd, \ub2e4\ubc1c\uc131 \uc678\uc0c1 \ud658\uc790 \uce58\ub8cc\ub97c \ub2f4\ub2f9\ud569\ub2c8\ub2e4. \uadf8\ub7ec\ub098 ASC\ub294 \uba54\ub514\ucf00\uc5b4 DRG(\uc9c4\ub2e8 \uad00\ub828 \uadf8\ub8f9) \ubc0f \ubbfc\uac04 \ubcf4\ud5d8\uc0ac\uc758 \uc120\ud0dd\uc801 \uc218\uc220\uc744 \uc800\ube44\uc6a9 \uc678\ub798 \ud5c8\ube0c\ub85c \uc720\ub3c4\ud568\uc5d0 \ub530\ub77c 2031\ub144\uae4c\uc9c0 6.38%\uc758 CAGR\ub85c \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc785\ub2c8\ub2e4. ASC\uc758 \uc804\uc2e0 \ub9c8\ucde8\uc81c \uc2dc\uc7a5 \uaddc\ubaa8\ub294 2025\ub144 16\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 23\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc99d\uac00\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uce58\uacfc \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9\uc740 \ubbf8\ub2e4\uc878\ub78c \ubc0f \uc800\uc6a9\ub7c9 \ud504\ub85c\ud3ec\ud3f4\uc744 \uc8fc\ub85c \uc0ac\uc6a9\ud558\uc5ec \uc758\uc2dd \uc9c4\uc815\uc744 \uc81c\uacf5\ud558\uba70, \uc804\uccb4 \uc9c0\ucd9c\uc758 5% \ubbf8\ub9cc\uc744 \ucc28\uc9c0\ud569\ub2c8\ub2e4.<\/p>\n<p># 5. \uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \uc804\uc2e0 \ub9c8\ucde8\uc81c \uc2dc\uc7a5 \ub9e4\ucd9c\uc758 38.50%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc785\ub2c8\ub2e4. \uc774\ub294 \uc120\uc9c4 \uc218\uc220 \uc778\ud504\ub77c, AI \uae30\ubc18 \uc804\ub2ec \uc2dc\uc2a4\ud15c\uc758 \uc870\uae30 \ucc44\ud0dd, \uadf8\ub9ac\uace0 \uc9c0\uc6d0\uc801\uc778 \ubcf4\ud5d8 \uc0c1\ud658 \uc815\ucc45\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. 6,100\uac1c\uc758 \uba54\ub514\ucf00\uc5b4 \uc778\uc99d ASC\uc640 2020\ub144 FDA \uc2b9\uc778 \uc774\ud6c4 \ub808\ubbf8\ub9c8\uc878\ub78c\uc758 \uc870\uae30 \ub3c4\uc785\uc774 \uc131\uc7a5\uc744 \uacac\uc778\ud588\uc2b5\ub2c8\ub2e4. \uce90\ub098\ub2e4\ub294 \ub2e8\uc77c \uc9c0\ubd88\uc790 \uc2dc\uc2a4\ud15c\uc73c\ub85c \uace0\uac00 \uc57d\ubb3c \ucc44\ud0dd\uc744 \uc81c\ud55c\ud558\uc9c0\ub9cc, \uc800GWP \uc804\ud658\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 5.22%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed\uc785\ub2c8\ub2e4. \uc218\uc220 \uac74\uc218 \uc99d\uac00, \uc218\uc220\uc2e4 \uc5c5\uadf8\ub808\uc774\ub4dc\ub97c \uc704\ud55c \uc815\ubd80 \uc778\uc13c\ud2f0\ube0c, \ud718\ubc1c\uc131 \ub9c8\ucde8\uc81c \ubc30\ucd9c\ub7c9 \uac10\ucd95\uc744 \uc704\ud55c \uad6d\uac00 \uc815\ucc45 \ub4f1\uc774 \uc131\uc7a5\uc744 \uc8fc\ub3c4\ud569\ub2c8\ub2e4. \uc911\uad6d\uc758 \ubbf8\ub2e4\uc878\ub78c \uaddc\uc81c \uac15\ud654\ub294 \ub808\ubbf8\ub9c8\uc878\ub78c\uc73c\ub85c\uc758 \uc804\ud658\uc744 \uc720\ub3c4\ud558\uace0 \uc788\uc73c\uba70, \uc778\ub3c4\uc758 GMP(\uc6b0\uc218 \uc758\uc57d\ud488 \uc81c\uc870 \ubc0f \ud488\uc9c8 \uad00\ub9ac \uae30\uc900) \uc900\uc218 \ud504\ub85c\uadf8\ub7a8\uc740 \uc81c\uc870 \ud488\uc9c8 \ud5a5\uc0c1\uc744 \ubaa9\ud45c\ub85c \ud569\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: \uc9c0\uc18d \uac00\ub2a5\uc131 \uc758\uc81c\ub85c \uc778\ud574 \ub370\uc2a4\ud50c\ub8e8\ub780\uc774 \ub2e8\uacc4\uc801\uc73c\ub85c \ud3d0\uc9c0\ub418\uba74\uc11c \uae30\ud68c\uc640 \uc81c\uc57d\uc774 \uacf5\uc874\ud569\ub2c8\ub2e4. \uc601\uad6d NHS\ub294 2024\ub144\uc5d0 \ub370\uc2a4\ud50c\ub8e8\ub780 \uc0ac\uc6a9\uc744 \uc804\uba74 \uc911\ub2e8\ud588\uc73c\uba70, \uc720\ub7fd \uc5f0\ud569\ub3c4 2026\ub144\uae4c\uc9c0 \uc9c0\uc5ed \uc804\uccb4 \uae08\uc9c0\ub97c \uac80\ud1a0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub3c5\uc77c\uacfc \uc2a4\uce78\ub514\ub098\ube44\uc544 \ubcd1\uc6d0\ub4e4\uc740 \ud718\ubc1c\uc131 \ud3ec\uc9d1 \uc2dc\uc2a4\ud15c\uc744 \uc2dc\ud5d8\ud558\uace0 \uc788\uc9c0\ub9cc, TIVA\uac00 \uc8fc\uc694 \uaddc\uc81c \uc900\uc218 \uacbd\ub85c\uac00 \ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. Fresenius\uc640 \uac19\uc740 \uc720\ub7fd \uacf5\uae09\uc5c5\uccb4\ub4e4\uc740 \uc8fc\uc0ac\uc81c \ub77c\uc778\uc744 \ud655\uc7a5\ud558\uba70 \ub300\uc751\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uc804\uc2e0 \ub9c8\ucde8\uc81c \uc0b0\uc5c5\uc740 Baxter, Fresenius, Pfizer\uc640 \uac19\uc740 \ub2e4\uad6d\uc801 \uae30\uc5c5\uc774 \ud575\uc2ec \ud761\uc785 \ubc0f \uc815\ub9e5 \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub97c \uc9c0\ubc30\ud558\ub294 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc785\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc2e0\ud765 \uae30\uc5c5\ub4e4\uc740 \ud2b9\uc218 \uc8fc\uc0ac\uc81c\ub97c \ud1b5\ud574 \ud2c8\uc0c8\uc2dc\uc7a5\uc744 \uacf5\ub7b5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. Baxter\ub294 \uc2e0\uc7a5 \uad00\ub9ac \uc0ac\uc5c5\ubd80 \ub9e4\uac01\uc744 \ud1b5\ud574 \ub9c8\ucde8 \ubc0f \uc8fc\uc0ac\uc81c \ubd84\uc57c\uc5d0 \uc9d1\uc911\ud558\uba70 \uace0\ub9c8\uc9c4 \uc804\ubb38 \ubd84\uc57c\ub85c\uc758 \uc804\ud658\uc744 \uac15\uc870\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. Amneal\uc740 \uacf5\uae09 \ubd80\uc871 \uae30\uac04 \ub3d9\uc548 \ud504\ub85c\ud3ec\ud3f4\uc744 \uacf5\uae09\ud558\uba70 \ubbfc\ucca9\ud55c \uc81c\uc870 \ub2a5\ub825\uc774 \uc2dc\uc7a5 \uc810\uc720\uc728 \ud655\ubcf4\uc5d0 \uc911\uc694\ud568\uc744 \uc785\uc99d\ud588\uc2b5\ub2c8\ub2e4. Mallinckrodt\uc640 Endo\uc758 \ud569\ubcd1\uacfc \uac19\uc740 \uc6c0\uc9c1\uc784\uc740 \ubb34\uade0 \uc8fc\uc0ac\uc81c \ubd84\uc57c\uc5d0\uc11c \uaddc\ubaa8\uc758 \uacbd\uc81c\ub97c \ucd94\uad6c\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc0b0\uc5c5 \ub9ac\ub354:<br \/>\n*   AbbVie Inc.<br \/>\n*   Baxter International Inc.<br \/>\n*   Fresenius SE &#038; Co. KGaA<br \/>\n*   Aspen Pharmacare Holdings Ltd.<br \/>\n*   B. Braun SE<\/p>\n<p>\ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5:<br \/>\n*   2025\ub144 10\uc6d4: GE HealthCare, \uc2e0\uc0dd\uc544\ubd80\ud130 \ub178\uc778\uae4c\uc9c0 \uc815\ubc00\ud55c \uc784\uc0c1 \uc801\uc6a9\uc774 \uac00\ub2a5\ud55c Carestation 850 \ub9c8\ucde8 \ud50c\ub7ab\ud3fc \uacf5\uac1c.<br \/>\n*   2025\ub144 4\uc6d4: Avenacy, \ubbf8\uad6d\uc5d0 3\uc138 \uc774\uc0c1 \ud658\uc790\uc758 \uc720\ub3c4 \ubc0f \uc720\uc9c0\uc5d0 \uc0ac\uc6a9\ub418\ub294 Diprivan \ub3d9\ub4f1 \uc81c\ud488\uc778 \ud504\ub85c\ud3ec\ud3f4 \uc8fc\uc0ac \uc720\uc81c(USP) \ucd9c\uc2dc.<br \/>\n*   2025\ub144 3\uc6d4: Mallinckrodt\uc640 Endo, 70\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \ud569\ubcd1 \ud569\uc758. 3\ub144 \ub0b4 1\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec\uc758 \uc2dc\ub108\uc9c0 \ud6a8\uacfc \ubaa9\ud45c.<br \/>\n*   2025\ub144 2\uc6d4: Teleflex, BIOTRONIK\uc758 \ud608\uad00 \uc911\uc7ac \uc0ac\uc5c5\ubd80\ub97c 7\uc5b5 6\ucc9c\ub9cc \uc720\ub85c(8\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec)\uc5d0 \uc778\uc218\ud558\uba70 \uc2ec\ud608\uad00 \ubd84\uc57c \ud655\uc7a5.<br \/>\n*   2025\ub144 2\uc6d4: Baxter, 2024\ub144 \ud68c\uacc4\uc5f0\ub3c4 \ub9e4\ucd9c 106\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec \ubcf4\uace0 \ubc0f \uc2e0\uc7a5 \uad00\ub9ac \uc0ac\uc5c5\ubd80 \ub9e4\uac01 \uc644\ub8cc \ud6c4 \ub9c8\ucde8 \ubc0f \uc911\ud658\uc790 \uc8fc\uc0ac\uc81c\uc5d0 \uc7ac\uc9d1\uc911.<\/p>\n<p>\uc774\ub7ec\ud55c \uc2dc\uc7a5 \ub3d9\ud5a5\uacfc \uacbd\uc7c1 \ud658\uacbd\uc740 \uc804\uc2e0 \ub9c8\ucde8\uc81c \uc2dc\uc7a5\uc774 \uc9c0\uc18d\uc801\uc778 \ud601\uc2e0\uacfc \ubcc0\ud654\ub97c \uacaa\uace0 \uc788\uc74c\uc744 \ubcf4\uc5ec\uc8fc\uba70, \ud2b9\ud788 \uc815\ub9e5 \ub9c8\ucde8\uc81c\uc640 \uce5c\ud658\uacbd \uc194\ub8e8\uc158\uc73c\ub85c\uc758 \uc804\ud658\uc774 \uac00\uc18d\ud654\ub420 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \uc804\uc2e0 \ub9c8\ucde8\uc81c \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc804\uc2e0 \ub9c8\ucde8\ub294 \uc758\ud559\uc801\uc73c\ub85c \uc720\ub3c4\ub41c \uac00\uc5ed\uc801\uc778 \ubb34\uc758\uc2dd \uc0c1\ud0dc\ub85c, \uc815\ub9e5 \uc8fc\uc0ac \uc57d\ubb3c\uacfc \ud761\uc785 \uac00\uc2a4\ub97c \uc870\ud569\ud558\uc5ec \ud658\uc790\uc758 \ud1b5\uc99d \uc81c\uac70, \uae30\uc5b5 \uc0c1\uc2e4 \ubc0f \uadfc\uc721 \uc774\uc644\uc744 \ubaa9\ud45c\ub85c \ud569\ub2c8\ub2e4.<\/p>\n<p>\uc804\uc2e0 \ub9c8\ucde8\uc81c \uc2dc\uc7a5\uc740 2025\ub144 56.6\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144\uae4c\uc9c0 67.4\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub418\uba70, \uc774\ub294 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 3.08%\uc5d0 \ud574\ub2f9\ud569\ub2c8\ub2e4. \uc2dc\uc7a5\uc740 \uc57d\ubb3c \uc720\ud615, \ud22c\uc5ec \uacbd\ub85c, \uc801\uc6a9 \ubd84\uc57c, \ucd5c\uc885 \uc0ac\uc6a9\uc790 \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \ubd84\uc11d\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc57d\ubb3c \uc720\ud615\uc73c\ub85c\ub294 \ud504\ub85c\ud3ec\ud3f4, \uc138\ubcf4\ud50c\ub8e8\ub780, \ub370\uc2a4\ud50c\ub8e8\ub780, \ub371\uc2a4\uba54\ub370\ud1a0\ubbf8\ub518, \ub808\ubbf8\ud39c\ud0c0\ub2d0, \ubbf8\ub2e4\uc878\ub78c, \uc5d0\ud1a0\ubbf8\ub370\uc774\ud2b8, \ucf00\ud0c0\ubbfc \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \ud504\ub85c\ud3ec\ud3f4\uc740 \uc804\uc815\ub9e5 \ub9c8\ucde8(TIVA) \ud504\ub85c\ud1a0\ucf5c \ubc0f \uc678\ub798 \uc218\uc220 \uc13c\ud130(ASC) \ubcf4\uae09 \ud655\uc0b0\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 4.98%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ud22c\uc5ec \uacbd\ub85c\ub294 \ud761\uc785 \ubc0f \uc815\ub9e5 \uc8fc\uc0ac(TIVA) \ubc29\uc2dd\uc774 \uc788\uc73c\uba70, \uc801\uc6a9 \ubd84\uc57c\ub294 \uc77c\ubc18 \uc218\uc220, \uc554 \uc218\uc220, \uc2ec\uc7a5 \uc218\uc220, \uc815\ud615\uc678\uacfc \uc218\uc220, \uc2e0\uacbd\uc678\uacfc \uc218\uc220 \ub4f1 \ub2e4\uc591\ud569\ub2c8\ub2e4. \ucd5c\uc885 \uc0ac\uc6a9\uc790\ub294 \ubcd1\uc6d0, \uc678\ub798 \uc218\uc220 \uc13c\ud130, \uc804\ubb38 \ubc0f \uce58\uacfc \ud074\ub9ac\ub2c9\uc73c\ub85c \uad6c\uc131\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc99d\uac00\ud558\ub294 \uc218\uc220\ub7c9, \uc2e0\uc81c\ud488 \uc2b9\uc778 \ubc0f \ucd9c\uc2dc \uc99d\uac00, \uc678\ub798 \uc218\uc220 \uc13c\ud130\uc758 \ud655\uc0b0, AI \uae30\ubc18 \ud3d0\uc1c4 \ub8e8\ud504 \uc8fc\uc785 \uc2dc\uc2a4\ud15c\uc758 \ub3c4\uc785, \uadf8\ub9ac\uace0 \ud658\uacbd \uce5c\ud654\uc801\uc778 \uc800\uc9c0\uad6c\uc628\ub09c\ud654\uc9c0\uc218(GWP) \ud761\uc785 \ub9c8\ucde8\uc81c\ub85c\uc758 \uc804\ud658 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. AI \uae30\ubc18 \ud3d0\uc1c4 \ub8e8\ud504 \uc2dc\uc2a4\ud15c\uc740 \ub1cc\ud30c(EEG) \uae4a\uc774 \ubaa8\ub2c8\ud130\ub9c1\uacfc \uc2a4\ub9c8\ud2b8 \ud38c\ud504\ub97c \ud1b5\ud569\ud558\uc5ec \ud504\ub85c\ud3ec\ud3f4 \ubc0f \ub808\ubbf8\ud39c\ud0c0\ub2d0 \uc0ac\uc6a9\ub7c9\uc744 \ucd5c\ub300 22%\uae4c\uc9c0 \uc904\uc774\uba74\uc11c \ud45c\uc900\ud654\ub41c \uce58\ub8cc\ub97c \uac00\ub2a5\ud558\uac8c \ud558\ub294 \ub4f1 \ud22c\uc57d \uad00\ud589\uc744 \ubcc0\ud654\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \uc57d\ubb3c\uc758 \ubd80\uc791\uc6a9 \ud504\ub85c\ud30c\uc77c \ubc0f \uc218\uc220 \ud6c4 \uc624\uc2ec \uad6c\ud1a0(PONV)\uc5d0 \ub300\ud55c \uc6b0\ub824, \uace0\uac00 \uc57d\ubb3c\uc5d0 \ub300\ud55c \ubcf4\ud5d8 \uc0c1\ud658 \uc555\ub825, \uc815\ub9e5 \uc8fc\uc0ac \uc720\uc81c\uc6a9 API-\uc9c0\uc9c8 \uacf5\uae09\ub9dd\uc758 \ubd88\uc548\uc815\uc131, \uadf8\ub9ac\uace0 \uace0GWP \uac00\uc2a4\uc5d0 \ub300\ud55c \ud658\uacbd\uc138 \ubd80\uacfc \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \ub370\uc2a4\ud50c\ub8e8\ub780\uc740 \ub192\uc740 GWP(2,540)\ub85c \uc778\ud574 \uc601\uad6d, \ub3c5\uc77c \ub4f1 \uc720\ub7fd \uad6d\uac00\uc5d0\uc11c \ud0c4\uc18c\uc138 \ubc0f \ud658\uacbd \uaddc\uc81c\uc758 \ub300\uc0c1\uc774 \ub418\uc5b4 \uc138\ubcf4\ud50c\ub8e8\ub780\uc774\ub098 TIVA\ub85c\uc758 \uc804\ud658\uc774 \uac00\uc18d\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591(Asia-Pacific) \uc9c0\uc5ed\uc774 \uc911\uad6d\uacfc \uc778\ub3c4\uc758 \ubcd1\uc6d0 \uac74\uc124 \uc99d\uac00 \ubc0f \uacbd\uc7c1\ub825 \uc788\ub294 \uc81c\ub124\ub9ad \uc758\uc57d\ud488 \ubcf4\uae09\uc5d0 \ud798\uc785\uc5b4 5.22%\uc758 CAGR\ub85c 2031\ub144\uae4c\uc9c0 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \uce21\uba74\uc5d0\uc11c \uc2dc\uc7a5\uc740 \uc0c1\uc704 5\uac1c \uc81c\uc57d\uc0ac\uac00 \uc804\uccb4 \ub9e4\ucd9c\uc758 \uc57d 45-50%\ub97c \ucc28\uc9c0\ud558\uba70 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc774\uc9c0\ub9cc, \uc81c\ub124\ub9ad \uc758\uc57d\ud488\uc758 \uce68\ud22c\uac00 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc8fc\uc694 \uae30\uc5c5\uc73c\ub85c\ub294 AbbVie Inc., Aspen Pharmacare Holdings Limited, AstraZeneca plc, Baxter International Inc., Fresenius Kabi AG, Pfizer Inc. \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5\uc758 \uae30\ud68c\uc640 \ubbf8\ub798 \uc804\ub9dd\uc744 \uc81c\uc2dc\ud558\uba70, \ubbf8\ucda9\uc871 \uc218\uc694\uc5d0 \ub300\ud55c \ud3c9\uac00\ub3c4 \ud3ec\ud568\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-54383","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/54383"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=54383"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/54383\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=54383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=54383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=54383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}